Company intelligence
OpenOnco
Independent source of information on cancer liquid biopsy tests.
Medical and Diagnostic Laboratories
1 employees
Founded 2025
3 public signals
About OpenOnco
Liquid biopsy tests are reshaping cancer treatment by profiling cancers from a simple blood draw. The tests are advancing rapidly - resulting in complex choices for doctors and patients. OpenOnco is a non-profit effort to consolidate test information and provide navigation tools to help match the right test to the right patient.
Verified activity
Signals from OpenOnco
3 published signals
Legal & Regulatory
OpenOnco notes that the FDA advisory committee reviewed Galleri, the first MCED test to reach one, on September 23.
Reported by Alex Dickinson
Legal & Regulatory
OpenOnco filed an extended form of three recommendations in an FDA docket for GRAIL's Galleri multi-cancer early detection test.
Reported by Alex Dickinson
Presence & Recognition
OpenOnco announced that the Elizabeth Holmes/Theranos documentary 'You Can See Everything' premiered at the Telluride Film Festival.
Reported by Alex Dickinson